The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy (Q46157399)
scientific article published on 19 January 2009
Language:
(P31) (Q13442814)
(P304) 592-595
(P407) (Q1860)
(P433) 3
(P478) 20
(P577) Monday, January 19, 2009
(P921) (Q19484)
(P1433) (Q326122)
(P1476) "The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy" (language: en)
(P2093) A Vazquez-Martin
C Oliveras-Ferraros
S del Barco
B Martin-Castillo
J A Menendez
(P2860) (Q36472437)
(Q37316206)
(Q36800953)
(Q35973421)
(Q39966294)
(Q22241965)
(Q40216291)
(Q40050621)
(Q40011785)
(Q40033668)
(Q40321985)
(Q46752587)
(Q27824819)
(Q40073729)
other details
description scientific article published on 19 January 2009

External Links